Ascentage Pharma Group International AAPG
NASDAQ AAPG
$15.81 +0.45 (+2.96%)
As of: Sep 30, 2026 · 10:08 AM EDT

Ascentage Pharma Group International (AAPG) Common Equity (2022 - 2026)

Updated

Ascentage Pharma Group International's Common Equity came in at $83.1 million for Q2 2026.

Analysis

Ascentage Pharma Group International (AAPG) Common Equity (2022 - 2026) Analysis & Trends

At the end of FY2025, Ascentage Pharma Group International's Common Equity was $190.79 million, up 408.0% from FY2024.

  • Common Equity carries a three-year compound annual growth rate of 46.4% (FY2022 to FY2025).
  • Going back by year, Common Equity was $37.56 million in FY2024 (+275.8%), $9.99 million in FY2023 (-83.6%) and $60.86 million in FY2022.
  • The Q2 2026 figure represents the lowest quarterly Common Equity since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Ascentage Pharma Group International 1.41 Bn 375.89 Mn - 83.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 83.10 Mn
Dec 31, 2025 188.11 Mn
Dec 31, 2024 38.17 Mn
Dec 31, 2023 9.81 Mn
Dec 31, 2022 57.46 Mn
API Access

Ascentage Pharma Group International Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=AAPG&period=max&api_key=YOUR_API_KEY